1 01/11/2023 31/10/2024 2024-10-31 true false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-11-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 15204378 2023-11-01 2024-10-31 15204378 2024-10-31 15204378 2023-10-31 15204378 bus:RegisteredOffice 2023-11-01 2024-10-31 15204378 bus:LeadAgentIfApplicable 2023-11-01 2024-10-31 15204378 bus:Director1 2023-11-01 2024-10-31 15204378 bus:Director2 2023-11-01 2024-10-31 15204378 bus:CompanySecretary1 2023-11-01 2024-10-31 15204378 core:ShareCapital 2023-11-01 2024-10-31 15204378 core:SharePremium 2023-11-01 2024-10-31 15204378 core:RetainedEarningsAccumulatedLosses 2023-11-01 2024-10-31 15204378 core:WithinOneYear 2024-10-31 15204378 core:ShareCapital 2024-10-31 15204378 core:SharePremium 2024-10-31 15204378 core:RetainedEarningsAccumulatedLosses 2024-10-31 15204378 core:PreviouslyStatedAmount core:ShareCapital 2024-10-31 15204378 bus:SmallEntities 2023-11-01 2024-10-31 15204378 bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 15204378 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 15204378 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 15204378 bus:FullAccounts 2023-11-01 2024-10-31 15204378 core:Associate1 2023-11-01 2024-10-31 15204378 core:Associate1 2024-10-31 15204378 1 2023-11-01 2024-10-31
Company registration number: 15204378
Intro Labs Ltd
Trading as Sendr
Unaudited filleted financial statements
31 October 2024
Intro Labs Ltd
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Intro Labs Ltd
Directors and other information
Directors Mr David Alexander Cannell
Mr John Haywood Bromley
Secretary David Alexander Cannell
Company number 15204378
Registered office Third Floor, Broadwalk House
Southernhay West
Exeter
EX1 1TS
Business address Third Floor, Boardwalk House
Southernhay West
Exeter
EX1 1TS
Accountants Hardcastle Blake
19 New Road
Drayton Parslow
Milton Keynes
MK17 0JH
Intro Labs Ltd
Statement of financial position
31 October 2024
2024
Note £ £
Current assets
Debtors 5 7,584
Cash at bank and in hand 245,112
_______
252,696
Creditors: amounts falling due
within one year 6 ( 27,351)
_______
Net current assets 225,345
_______
Total assets less current liabilities 225,345
_______
Net assets 225,345
_______
Capital and reserves
Called up share capital 7 1,349
Share premium account 387,150
Profit and loss account ( 163,154)
_______
Shareholders funds 225,345
_______
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 27 February 2025 , and are signed on behalf of the board by:
Mr David Alexander Cannell Mr John Haywood Bromley
Director Director
Company registration number: 15204378
Intro Labs Ltd
Statement of changes in equity
Year ended 31 October 2024
Called up share capital Share premium account Profit and loss account Total
£ £ £ £
At 1 November 2023 - - - -
Loss for the year ( 163,154) ( 163,154)
_______ _______ _______ _______
Total comprehensive income for the year - - ( 163,154) ( 163,154)
Issue of shares 1,349 387,150 388,499
_______ _______ _______ _______
Total investments by and distributions to owners 1,349 387,150 - 388,499
_______ _______ _______ _______
At 31 October 2024 1,349 387,150 ( 163,154) 225,345
_______ _______ _______ _______
Intro Labs Ltd
Notes to the financial statements
Year ended 31 October 2024
1. General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is Third Floor, Broadwalk House, Southernhay West, Exeter, EX1 1TS.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for services rendered, net of discounts and Value Added Tax.
When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period.
When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Research and development
Research expenditure is written off in the year in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1
5. Debtors
2024
£
Other debtors 7,584
_______
6. Creditors: amounts falling due within one year
2024
£
Social security and other taxes 1,643
Other creditors 25,708
_______
27,351
_______
7. Called up share capital
On incorporation the company issued 1,000 ordinary shares to the founders. During the year the company issued a further 349 ordinary shares to investors at a premium to investors under the EIS scheme
8. Related party transactions
Transaction value Balance owed by /(owed to)
Year Year
ended ended
2024 2024
£ £
Chief Growth Limited 4,050 ( 4,050)
_______ _______
During the year, Chief Growth Limited (owned by Mr D Cannell - director)
incurred costs of £4.050 on behalf of the company.
There is no set repayment date for this
9. Controlling party
The company is jointly controlled by Mr D Cannell and Mr J Bromley - directors by virtue of their share ownership and voting rights exceeding 50%